Trials / Completed
CompletedNCT01298440
Bevacizumab Effect on Blood Velocity
The Effect of Intravitreal Bevacizumab (Avastin) Injection on Retinal Blood-Flow Velocity in Patients With Choroidal Neovascularization
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Optical Imaging, Ltd. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Retinal blood flow velocity is affected by Bevacizump intravitreal injection. This effect is correlated to treatment success.
Detailed description
The purpose of the study was to carry out a pilot study on the short-term effect of intravitreal Bevacizumab (Avastin) injection on retinal blood-flow velocity and test whether the short-term haemodynamic changes could predict the longer term clinical result of the treatment.
Conditions
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2008-06-01
- Completion
- 2008-06-01
- First posted
- 2011-02-17
- Last updated
- 2011-02-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01298440. Inclusion in this directory is not an endorsement.